Regional Services Plan – Q1 reporting
Regional salivary gland function after radiotherapy of head and neck
Regional Primary Care Lead Contact
Regional Nodal Irradiation in Early
Regional Differences in Breast Cancer Survival Despite Common
Regional Chemotherapy in Locally Advanced Pancreatic Cancer
Regional challenges in cancer prevention
Regional Breast Cancer Self Directed Aftercare Pathway
Regimen: Vinorelbine (Oral) for Advanced Breast Cancer
Regimen: Pegylated Liposomal Doxorubicin Hydrochloride (PLDH
Regimen: Paclitaxel weekly for Breast Cancer
Regimen: Liposome-encapsulated Doxorubicin (Myocet )
Regimen: Docetaxel, Carboplatin and Trastuzumab (TCH i.e.
Regimen: Cisplatin and Gemcitabine
Regimen: Carboplatin and Paclitaxel in combination with
Regimen : Oxaliplatin+Modified de Gramont (FOLFOX)
Regimen : Cisplatin and Radiotherapy for Head and Neck Cancers
Regimen : Carboplatin + Etoposide for small cell lung cancer
Regence BlueShield | Regence Silver 3000 Preferred | Summary of
refusal of faecal occult blood testing in a general practice in England
